Martin Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Sell
41,803
-138
-0.3% -$32.2K 3.9% 3
2026
Q1
$10.3M Sell
41,941
-430
-1% -$100K 3.81% 3
2025
Q4
$8.77M Sell
42,371
-1,099
-3% -$217K 3.3% 6
2025
Q3
$8.06M Sell
43,470
-832
-2% -$143K 3.13% 6
2025
Q2
$6.77M Buy
44,302
+30,079
+211% +$4.62M 2.65% 12
2025
Q1
$2.36M Sell
14,223
-277
-2% -$43.3K 2.82% 10
2024
Q4
$2.1M Sell
14,500
-17,002
-54% -$2.63M 2.49% 13
2024
Q3
$5.11M Sell
31,502
-10,616
-25% -$1.69M 2.52% 12
2024
Q2
$6.16M Sell
42,118
-1,048
-2% -$156K 2.49% 13
2024
Q1
$6.83M Sell
43,166
-423
-1% -$67.3K 2.62% 13
2023
Q4
$6.83M Sell
43,589
-557
-1% -$85.4K 2.79% 9
2023
Q3
$6.88M Buy
44,146
+150
+0.3% +$24.8K 2.89% 8
2023
Q2
$7.28M Sell
43,996
-832
-2% -$134K 2.96% 4
2023
Q1
$6.95M Buy
44,828
+3,005
+7% +$485K 2.89% 6
2022
Q4
$7.39M Buy
41,823
+558
+1% +$96.3K 3.05% 7
2022
Q3
$6.74M Buy
41,265
+2,132
+5% +$361K 3.13% 3
2022
Q2
$6.95M Buy
39,133
+915
+2% +$163K 3.3% 3
2022
Q1
$6.77M Buy
38,218
+1,617
+4% +$275K 3.09% 3
2021
Q4
$6.26M Buy
36,601
+116
+0.3% +$19K 2.96% 5
2021
Q3
$5.89M Buy
36,485
+48
+0.1% +$8.19K 2.98% 6
2021
Q2
$6M Buy
36,437
+202
+0.6% +$33.4K 3.04% 5
2021
Q1
$5.96M Sell
36,235
-848
-2% -$137K 3.16% 5
2020
Q4
$5.84M Sell
37,083
-159
-0.4% -$23.5K 3.41% 4
2020
Q3
$5.54M Sell
37,242
-1,103
-3% -$163K 3.71% 5
2020
Q2
$5.39M Sell
38,345
-2,199
-5% -$320K 3.79% 4
2020
Q1
$5.32M Sell
40,544
-207
-0.5% -$29.4K 4.05% 2
2019
Q4
$5.94M Buy
40,751
+1,046
+3% +$142K 3.51% 3
2019
Q3
$5.14M Buy
39,705
+1,195
+3% +$157K 3.46% 2
2019
Q2
$5.36M Buy
38,510
+1,407
+4% +$195K 3.79% 2
2019
Q1
$5.19M Buy
37,103
+3,661
+11% +$490K 4% 2
2018
Q4
$4.32M Buy
33,442
+1,409
+4% +$197K 3.98% 3
2018
Q3
$4.43M Buy
32,033
+698
+2% +$92.8K 3.97% 2
2018
Q2
$3.8M Sell
31,335
-1,426
-4% -$178K 3.88% 2
2018
Q1
$4.2M Buy
32,761
+282
+0.9% +$38.1K 4.18% 3
2017
Q4
$4.54M Buy
+32,479
New +$4.52M 4.71% 1

Other funds holding JNJ

Martin Capital Partners's JNJ Position: Q2 2026 in Review

Martin Capital Partners reduced its Johnson & Johnson (JNJ) stake by 0.33% in Q2 2026, selling an estimated $32.2K and leaving 41,803 shares worth $10.6M. The position accounts for 3.9% of the portfolio, ranked #3.

Martin Capital Partners first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Martin Capital Partners held 41,803 shares of Johnson & Johnson worth $10.6M as of Q2 2026.
  • Martin Capital Partners sold 138 Johnson & Johnson shares in Q2 2026, an estimated $32.2K.
  • Johnson & Johnson made up 3.9% of Martin Capital Partners's portfolio in Q2 2026, its #3 holding.
  • Martin Capital Partners first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Martin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.